Published in Obesity and Diabetes Week, June 6th, 2005
According to recent research from Turkey, "The aim of the present study was the evaluation of possible protective effects of quercetin (QE) against beta-cell damage in experimental streptozotocin (STZ)-induced diabetes in rats. STZ was injected intraperitoneally at a single dose of 50 mg/kg for diabetes induction. QE [15 mg/kg day, intraperitoneal (i.p.) injection] was injected for 3 days prior to STZ administration; these injections were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.